ArticleMedical oncology (Northwood, London, England)2014
Development of breast tumors in CHEK2, NBN/NBS1 and BLM mutation carriers does not commonly involve somatic inactivation of the wild-type allele.
Evgeny N Suspitsin et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
16 papers cite it
this paperpooled itcites it